IRCT20170609034406N8尚未招募3 期
Evaluation of the effect of pentoxifylline in reducing the complications of Covid _19
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 75 years（—）
- 性别
- All
入选标准
- •Positive PCR test for nasopharyngeal sample or certain evidence indicating Covid-19 disease
- •Moderate to mild symptoms
- •onset of symptoms within 7 days
- •Ability to swallow
- •Age between 18 and 75
排除标准
- •Shock state or multi-organ failure
- •Chronic liver disease
- •Chronic kidney disease
- •Pregnancy and lactation
- •Participation in other clinical studies
- •Receiving drugs with severe interaction with pentoxifylline
研究者
相似试验
尚未招募
3 期
Evaluation of the effect of pentoxifylline on the prevention of erythrocyte lysis in cardiac surgery patientsAll patients undergo open heart surgery.IRCT20210420051018N1Semnan University of Medical Sciences15
已完成
2 期
The evaluation of the effect of pentoxifylline on diabetic foot ulcersIRCT20180818040823N1Tehran University of Medical Sciences18
已完成
3 期
The effect of Pentoxifylline in patients with Covid-19IRCT20200705048013N1Karaj University of Medical Sciences150
尚未招募
2 期
The effect of Pentoxifylline for the treatment of major depression in cardiovascular patientsIRCT20090117001556N132Tehran University of Medical Sciences50
招募中
3 期
Evaluating the effectiveness of pentoxifylline on the prevention of gentamicin nephrotoxicityIRCT20161010030246N5Shiraz University of Medical Sciences60